Emcure Board Approves Director Reappointments

Emcure Pharmaceuticals Board approves reappointment of Dr. Mukund Gurjar as Whole-time Director for one year from August 28, 2026.
Board approves reappointment of Mr. Satish Mehta as Managing Director for five years from April 1, 2027, subject to shareholder approval.
Disclosure confirms directors are not debarred by SEBI and provides detailed professional profiles and family relationships.